FDA inspection
Janssen Pharmaceuticals, Inc.: FDA inspection ending Jan 21, 2000
FDA inspection 11031 · No Action Indicated (NAI) · Titusville, NJ
Key facts
| Inspection ID | 11031 |
|---|---|
| Firm | Janssen Pharmaceuticals, Inc. |
| FEI number | 2242843 |
| Address | 1125 Trenton Harbourton Rd |
| City | Titusville |
| State | NJ |
| ZIP | 08560-1504 |
| Fiscal year | 2000 |
| Inspection end date | Jan 21, 2000 |
| Classification | No Action Indicated (NAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data